News & events
Why I founded the Psychotropic Deprescribing Council
What medical school doesn't teach Recent 2022 US Centers for Disease Control data show that at any one time, about 25% of the US adult population takes at least one…
How consultant pharmacist Dr. DeLon Canterbury helps patients safely go off psychotropic drugs
DeLon Canterbury, PharmD, BCGP, a pharmacist with a private deprescribing practice, discusses how he helps patients design a taper schedule and technical aspects of customized psychotropic dosing. He also reviews…
Hyperbolic Tapering Tips: Enablers and Barriers, with Mark Horowitz, MBBS PhD
Psychiatric researcher and clinician Mark Horowitz, MBBS, PhD, originator of the Horowitz-Taylor method for hyperbolic tapering of psychotropics and lead author of the 2024 Maudsley Deprescribing Guidelines for Antidepressants, Benzodiazepines,…
Bridging to Recovery While Deprescribing Psychiatric Drugs, with Anders Sørensen, PhD
When psychiatric drug treatment comes to an end, how may a clinician minimize the risk of withdrawal or relapse while deprescribing? In this webinar presented by the Psychotropic Deprescribing Council,…
The Therapist’s Role in the Psychotropic Deprescribing Process,with Dr. Anne Guy and Angela Peacock, MSW
The Psychotropic Deprescribing Council is pleased to announce a virtual roundtable about the role of therapists in the deprescribing of psychiatric and other psychotropic drugs. Dr. Anne Guy (PsychD), UKCP…
Support us with a donation
As a registered 501(c)3 charity, we rely upon your financial support.
